Friday Pre-Market Look: Stocks In The News Before The Open

Ruby Tuesday (RT) tumbled 19% in after-hours trading after it reported Q2 revenue of $214.7 million versus $261 million y/y, and said same-restaurant sales were “disappointing” due to a net reduction of 109 company-owned restaurants

Quotient Ltd (QTNT) jumped 18% in after-hours trading after it reported positive results from MosaiQ study for antigen typing and affirmed that European field trials for blood grouping and initial disease screening panel to be completed in the first half of 2017.

Stemline Therapeutics (STML) surged over 20% in after-hours trading after it reported a “positive” meeting with the FDA on an expedited registration pathway to full approval of its SL-401, a treatment for an aggressive form of leukemia.

Travelers (TRV) was downgraded to ‘Underweight’ from ‘Neutral’ at Atlantic Equities LLP with a 12-month target price of $110.

McDonald’s (MCD) was downgraded to ‘Neutral’ from ‘Buy’ at UBS with a 12-month target price of $130.

The Gap (GPS) jumped 12% in after-hours trading after Retail Metrics reported an unexpected 4% increase in December total comparable sales, stronger than consensus of a -1.7% decline.

Amgen (AMGN) rallied over 5% in after-hours trading after it won a court ruling blocking Sanofi and Regeneron from selling their Praluent cholesterol-lowering drug in the U.S. because it infringes patents. Regeneron (REGN -0.57%) dropped 1% and Sanofi (SNY +1.59%) slid 3% on the news.

Burlington Stores (BURL) was rated a new ‘Outperform’ at Wedbush with a 12-month target price of $107.

G-III Apparel Group Ltd (GIII) sold-off 8% in after-hours trading after it cut its view on 2017 adjusted Ebitda to $148 million-$155 million from a prior view of $163 million-$171 million.

Expedia (EXPE) gained almost 1% in after-hours trading after it was upgraded to ‘Buy’ from ‘Hold’ at Stifel.

Helen of Troy Ltd (HELE) climbed 3% in after-hours trading after it reported Q3 adjusted EPS of $2.37, higher than consensus of $1.90, and said it sees fiscal 2017 adjusted EPS of $6.20-$6.50, above consensus of $6.13.

Momenta Pharmaceuticals (MNTA) climbed 7% in after-hours trading after it joined into a pact with CSL to develop and commercialize Fc mutimer proteins and will receive $50 million in upfront license fee and is eligible for up to $550 million in potential clinical, regulatory and commercialization milestones.

Summit Materials (SUM) fell over 5% in after-hours trading after it offered 10 million shares of common stock.

Pandora Media (P) fell over 2% in after-hours trading after Sirius XM CFO said M&A with Pandora is “not very likely.”

Source: FoxBusiness, Barchart, Bloomberg, Reuters